Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""MARCEAU, Armelle"" wg kryterium: Autor


Tytuł :
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
Autorzy :
MARQUETTE, Charles-Hugo
BOUTROS, Jacques
Benzaquen, Jonathan
FERREIRA, Marion
PASTRE, Jean
Pison, Christophe
PADOVANI, Bernard
BETTAYEB, Faiza
FALLET, Vincent
GUIBERT, Nicolas
BASILLE, Damien
ILIE, Marius
HOFMAN, Véronique
HOFMAN, Paul
ISRAEL-BIET, Dominique
CHABOT, François
GUILLAUMOT, Anne
DESLEE, Gaetan
PEROTIN, Jeanne-Marie
DURY, Sandra
MAL, Hervé
MARCEAU, Armelle
Kessler, Romain
Vergnon, Jean-Michel
Pelissier, Carole
Di Palma, Fabrice
Cuvelier, Antoine
PATOUT, Maxime
Bourdin, Arnaud
GAMEZ, Anne Sophie
ANDREJAK, Claire
POULET, Claire
FRANCOIS, Géraldine
Jounieaux, Vincent
Roche, Nicolas
Jouneau, Stéphane
Brinchault, Graziella
Bonniaud, Philippe
ZOUAK, Ayoub
Scherpereel, Arnaud
BALDACCI, Simon
CORTOT, Alexis
Mornex, Jean François
Steenhouwer, François
LEROY, Sylvie
BERTHET, Jean-Philippe
FONTAS, Eric
BULSEI, Julie
CRUZEL, Coralie
Pradelli, Johanna
Fontaine, Maureen
MANIEL, Charlotte
Griffonnet, Jennifer
BUTORI, Catherine
SELVA, Eric
POUDENX, Michel
AguilanIu, Bernard
Ferreti, Gilbert
Arbib, François
Briault, Amandine
Toffart, Anne-Claire
Dahalani, Raissa
Destors, Marie
Chanez, Pascal
GREILLIER, Laurent
ASTOUL, Philippe
BARLESI, Fabrice
GAUBERT, Jean-Yves
Mazières, Julien
Marchand-Adam, Sylvain
Cadranel, Jacques
CHAABANE, Nouha
IZADIFAR, Armine
ROSENCHER, Lise
RUPPERT, Anne-Marie
VIEIRA, Thibault
MATHIOT, Nathalie
Marquette, Charles-Hugo
Pokaż więcej
Źródło :
In The Lancet Respiratory Medicine July 2020 8(7):709-716
Czasopismo naukowe
Tytuł :
Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
Autorzy :
Bulsei, Julie
Leroy, Sylvie
Perotin, Jeanne-Marie
Mal, Hervé
Marquette, Charles-Hugo
Dutau, Hervé
Bourdin, Arnaud
Vergnon, Jean-Michel
Pison, Christophe
Kessler, Romain
Jounieaux, Vincent
Salaün, Mathieu
Marceau, Armelle
Dukic, Sylvain
Barbe, Coralie
Bonnaire, Margaux
Deslee, Gaëtan
Durand-Zaleski, Isabelle
the REVOLENS study group
Pokaż więcej
Źródło :
Respiratory Research. 19(1)
Czasopismo naukowe
Tytuł :
Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2.
Autorzy :
Valipour A; Department of Respiratory and Critical Care Medicine, Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Krankenhaus Nord-Klinik Floridsdorf, Vienna, Austria.
Shah PL; Royal Brompton & Harefield NHS Trust, Chelsea & Westminster Hospital and Imperial College, London, UK.
Herth FJ; Thoraxklinik, Department of Pneumology and Critical Care Medicine and Translational Lung Research Center Heidelberg (TLRCH), University of Heidelberg, Heidelberg, Germany.
Pison C; CHU Grenoble Alpes, Service Hospitalier Universitaire Pneumologie Physiologie; Université Grenoble Alpes, Grenoble, France.
Schumann C; Clinic of Pneumology, Thoracic Oncology, Sleep- and Respiratory Critical Care, Klinikverbund Allgaeu, Kempten and Immenstadt, Germany.
Hübner RH; Charité Universitätsmedizin Berlin, Medizinische Klinik m. Schw. Infektiologie und Pneumologie, Campus Virchow, Berlin, Germany.
Bonta PI; Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Kessler R; Service de Pneumologie, Nouvel Hôpital Civil, Université de Strasbourg, Strasbourg, France.
Gesierich W; Asklepios-Fachkliniken Munich-Gauting, Comprehensive Pneumology Center Munich, Gauting, Germany.
Darwiche K; Department of Pulmonary Medicine, Section of Interventional Pneumology, Ruhrlandklinik - University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Lamprecht B; Department of Pulmonary Medicine, Kepler Universitatsklinikum GmbH, Linz, Austria.
Perez T; CHU de Lille - Hôpital Calmette, Lille, France.
Skowasch D; Department of Internal Medicine II - Cardiology/Pneumology, University of Bonn, Bonn, Germany.
Deslee G; CHU de Reims, Hôpital Maison Blanche, Service de Pneumologie, Reims, France.
Marceau A; Service de Pneumologie, Hôpital Universitaire Bichat, Paris, France.
Sciurba FC; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Gosens R; Department of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Hartman JE; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Conway F; Royal Brompton & Harefield NHS Trust, Chelsea & Westminster Hospital and Imperial College, London, UK.
Duller M; Department of Respiratory and Critical Care Medicine, Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Krankenhaus Nord-Klinik Floridsdorf, Vienna, Austria.
Mayse M; Nuvaira, Inc., Minneapolis, MN, USA.
Norman HS; Nuvaira, Inc., Minneapolis, MN, USA.
Slebos DJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Pokaż więcej
Corporate Authors :
AIRFLOW-2 Trial Study Group
Źródło :
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2020 Nov 05; Vol. 15, pp. 2807-2816. Date of Electronic Publication: 2020 Nov 05 (Print Publication: 2020).
Typ publikacji :
Case Reports; Clinical Trial
Raport
Tytuł :
Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.
Autorzy :
Deslée G; Service de Pneumologie, INSERM U903, Hôpital Universitaire, Reims, France .
Leroy S; Service de Pneumologie, CHU de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Perotin JM; Service de Pneumologie, INSERM U903, Hôpital Universitaire, Reims, France.
Mal H; Service de Pneumologie, Hôpital Universitaire Bichat, Paris, France.
Dutau H; Service d'Oncologie Thoracique, Maladies de la Plèvre, Pneumologie Interventionnelle, Hôpital Universitaire, Marseille, France.
Bourdin A; Département de Pneumologie et Addictologie, PhyMedExp, INSERM U1046, CNRS UMR, Hôpital Universitaire, Montpellier, France.
Vergnon JM; Service de Pneumologie, Hôpital Universitaire, Saint Etienne, France.
Pison C; Clinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux, Inserm1055, Hôpital Universitaire Grenoble Alpes, Inserm1055, Université Grenoble Alpes, Grenoble, France.
Kessler R; Service de Pneumologie, Hôpital Universitaire, Strasbourg, France.
Jounieaux V; Service de Pneumologie, Hôpital Universitaire, Amiens, France.
Salaün M; Service de Pneumologie, Oncologie Thoracique et Soins Intensifs Respiratoires, Hôpital Universitaire, Rouen, France.
Marceau A; Service de Pneumologie, Hôpital Universitaire Bichat, Paris, France.
Dury S; Service de Pneumologie, INSERM U903, Hôpital Universitaire, Reims, France.
Benzaquen J; Service de Pneumologie, CHU de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Bonnaire M; Département de Méthodologie, Pôle Recherche-Innovations, Hôpital Universitaire, Reims, France.
Dukic S; Unité de vigilance des essais cliniques, Hôpital Universitaire, Reims, France.
Barbe C; Département de Méthodologie, Pôle Recherche-Innovations, Hôpital Universitaire, Reims, France.
Marquette CH
Pokaż więcej
Corporate Authors :
, on behalf of the REVOLENS Study Group13
REVOLENS Study Group
Źródło :
The European respiratory journal [Eur Respir J] 2017 Dec 21; Vol. 50 (6). Date of Electronic Publication: 2017 Dec 21 (Print Publication: 2017).
Typ publikacji :
Letter; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Bronchoscopy/*instrumentation
Postoperative Complications/*epidemiology
Pulmonary Emphysema/*surgery
Alloys ; Bronchoscopy/adverse effects ; Exercise Tolerance ; Female ; Follow-Up Studies ; France/epidemiology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Pulmonary Emphysema/physiopathology ; Quality of Life ; Treatment Outcome
Raport
Tytuł :
Functional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patients.
Autorzy :
Dauriat G; Department of Pneumology Hôpital Beaujon, Clichy, France.
Mal H
Jebrak G
Brugière O
Castier Y
Camuset J
Marceau A
Taillé C
Lesèche G
Fournier M
Pokaż więcej
Źródło :
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2006; Vol. 1 (2), pp. 201-6.
Typ publikacji :
Journal Article
MeSH Terms :
Emphysema/*complications
Emphysema/*surgery
Pneumonectomy/*methods
alpha 1-Antitrypsin Deficiency/*complications
alpha 1-Antitrypsin Deficiency/*surgery
Emphysema/physiopathology ; Forced Expiratory Volume ; Humans ; Middle Aged ; Respiratory Function Tests ; alpha 1-Antitrypsin Deficiency/physiopathology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies